SM
BITI icon

Sabby Management’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Sabby Management’s Portfolio BITI Stock Details BITI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-50,460
Closed -$714K – 397
2015
Q4 		$714K Buy
50,460
+10,460
+26% +$146K 0.04% 213
2015
Q3 		$524K Buy
+40,000
New +$703K 0.02% 289

Other funds holding BITI

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
GL
GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return

Sabby Management's BITI Position: Q1 2016 in Review

Sabby Management sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q1 2016, closing a stake of 50,460 shares — an estimated $714K sold.

Sabby Management first reported a position in BITI in Q3 2015 and held it in 2 quarters. The position peaked at $714K in Q4 2015. 19 funds tracked by Wall St. Rank hold BITI as of Q1 2016.

  • Sabby Management reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q1 2016 after selling out during the quarter.
  • Sabby Management sold 50,460 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q1 2016, an estimated $714K.
  • Sabby Management first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q3 2015 and held it in 2 quarters.
  • Sabby Management's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $714K in Q4 2015.
  • 19 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.